Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
about
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusPlacental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnanciesSpecial considerations in pregnant systemic sclerosis patients.Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosusEULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromePregnancy in Women with Systemic Lupus Erythematosus: A Retrospective Study of 83 Pregnancies at a Single CentreSystemic lupus erythematosus pregnancies: ten-year data from a single centre in Malaysia.Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies.Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.Pregnancy and autoimmune connective tissue diseasesCharacteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study.Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes.Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.What Causes Lupus Flares?Early-onset Preeclampsia in Lupus Pregnancy.Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus.Current status and future prospects for the treatment of antiphospholipid syndrome.Pregnancies in women with systemic lupus erythematosus and antiphospholipid antibodies.Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines.Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy OutcomesRacial and Ethnic Disparities in the Pregnancies of Women With Systemic Lupus Erythematosus.Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.Medication use among pregnant women with systemic lupus erythematosus and general population comparators.Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus.Brief Report: Causes of Stillbirths in Women With Systemic Lupus Erythematosus.Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study.Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screening.High risk of postpartum relapses in neuromyelitis optica spectrum disorder.Clinical features of new-onset systemic lupus erythematosus in pregnant patients.Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births.Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study.Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.Complement activation, a threat to pregnancy.Antiphospholipid Antibodies Inhibit Trophoblast Toll-like Receptor and Inflammasome Negative Regulators.
P2860
Q28072610-C750D8FD-A23A-4BEF-ABED-B0F9659FA801Q28603356-9DCB917F-9248-4249-972C-131BED2C52FFQ30244385-E5A48DB7-BFD3-489D-B752-603B83A08BD1Q33602398-8490309D-C4C9-415E-830F-DB63A9187C61Q33731711-A8AD2DC0-2883-42B3-AE4C-64DBD6C4C416Q36013011-D3085AF4-22F0-4240-8C23-579F6D1A789CQ36103610-D524570E-96CB-421E-B6D5-248B63F6F240Q36259509-679C25C9-A331-4402-A85D-B7AEF1B05033Q36421501-B726B44A-E206-466F-8F43-29D28CD26B72Q36472645-A486A753-BA06-4B32-8BC6-FDD599DEE8A4Q37087437-B7F8DFEF-3E41-4D4C-AF64-73AC5FCCFE3AQ37100267-15D32F76-DD70-4CB6-9E9D-A57D60362ABBQ37312560-78CC42ED-F766-402C-A2C8-E2F4C32F8A4AQ37690515-5BC17EBB-C308-4EFA-8AF2-407D78DD41AAQ38657043-639F7DB0-A148-4260-84BA-FAC825D8CD41Q38764104-FEE1E3D1-ADC1-4777-BDB4-58D81FAB502DQ38784029-7DBD0079-EBC2-460A-8AE2-0E033684D904Q38798999-DE84A2BA-0D89-4891-9390-072FD1D1EA3BQ38818425-DA42924B-289C-44DB-BBF2-B217CCC51521Q38916073-3684ADC7-5437-4E0C-96DD-2DCE917644ABQ39150632-1B715D15-1960-4DFC-8CD3-3975A305E282Q39264755-DBC308AF-7542-4267-A548-4D9B9EA5B177Q39316691-045DB29A-E65C-4498-B805-F466C245BFD4Q39909645-5CC615BD-4794-4F82-B091-248A4CFB858EQ40055564-54D68575-E438-44BF-B5CF-45CA6EDAD007Q40305897-44159160-75DA-449F-B466-EE53BC95BBB2Q40408617-EB71C344-9013-4746-970A-06BEC86DE158Q40556363-106C95F8-E4BB-40DE-831D-ECF51D21B355Q40763560-27114E8E-19F8-4451-B4FD-4A0C6898BF8FQ43180633-4F0E826E-520E-4124-AFC4-1932E3534D3AQ46000897-7FEDCD07-9685-426B-B26A-13E0F8CE202DQ46160275-64D14C58-5550-442C-93F0-3BC256CE16A1Q47193567-C41A12F6-ABEE-4ACF-A87E-15142B5E7488Q47275497-6B5F36FB-8104-4CD6-9635-B3B045910173Q47552842-BC251AE2-05B0-42C1-AE08-D9D636D13DEDQ47796610-5517DCB0-82D4-45B2-AF42-44D41BA356B2Q47807744-9CA8F6A6-7F7F-4921-A964-6D7CBF828073Q48164014-87CB5D8B-F1C4-431D-A636-BCCD7C018734Q48662976-42CD2ED8-C050-4896-85E3-0D27C0652135Q49998565-0E1843C5-7F03-478A-A8B5-07E5EAB5FFC4
P2860
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@en
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@nl
type
label
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@en
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@nl
prefLabel
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@en
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@nl
P2093
P2860
P356
P1476
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
@en
P2093
Allen Sawitzke
Carl A Laskin
D Ware Branch
Elisabeth Cohn
Jane E Salmon
Jill P Buyon
Joan T Merrill
Lamya Garabet
Lisa Sammaritano
Marta M Guerra
P2860
P304
P356
10.7326/M14-2235
P407
P577
2015-08-01T00:00:00Z